Detection of miRNA expression profiles in different clinical stages of nasopharyngeal carcinoma (NPC) and NPC lymph node metastasis shows that the expression of miR-149 is upregulated in NPC and expression of its target gene, Smad2, is decreased with the progression of NPC [38]. The gene discussed is SMAD2; the disease is nasopharyngeal carcinoma.